Treatment Action Group (TAG) Revenue and Competitors
Estimated Revenue & Valuation
- Treatment Action Group (TAG)'s estimated annual revenue is currently $3.5M per year.
- Treatment Action Group (TAG)'s estimated revenue per employee is $159,091
Employee Data
- Treatment Action Group (TAG) has 22 Employees.
- Treatment Action Group (TAG) grew their employee count by 10% last year.
Treatment Action Group (TAG)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | U.S. and Global Health Policy Director | Reveal Email/Phone |
3 | TB Project Officer | Reveal Email/Phone |
4 | HIV Community Engagement Officer | Reveal Email/Phone |
5 | Co Director, Tuberculosis Project | Reveal Email/Phone |
6 | Communications Director | Reveal Email/Phone |
7 | HIV Progam Manager | Reveal Email/Phone |
8 | HIV/HCV Project Co-Director | Reveal Email/Phone |
9 | Consultant, HCV project | Reveal Email/Phone |
What Is Treatment Action Group (TAG)?
T A G TREATMENT ACTION GROUP INC is a company based out of 261 5TH AVE RM 2110, NEW YORK, New York, United States.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.5M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Treatment Action Group (TAG) News
2022-04-20 - Technology + People is Key to Improving Health Outcomes ...
Billing, lack of time and staffing · Solo practices: 38% reported that their top stressor is billing or insurance issues · Group practices: 35% responded that...
2022-04-19 - Editas gets good news in form of pediatric disease tag
Editas sees clinical promise with new FDA pediatric disease tag for ... Editas holds its patents with this group and saw a bump in its share...
2022-04-17 - Hepatitis and HIV Groups Protest 340B Restrictions to Low ...
Hepatitis and HIV Groups Protest 340B Restrictions to Low-Cost Drugs ... The AIDS Institute and Treatment Action Group (TAG).
Other Companies in NEW YORK
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.3M | 22 | -27% | N/A |
#2 | $2.2M | 22 | -63% | $30M |
#3 | $2.5M | 22 | -15% | N/A |
#4 | $2.2M | 22 | N/A | N/A |
#5 | $2.2M | 22 | N/A | N/A |